Intronic variant in IQGAP3 associated with hereditary neuropathy with proximal lower dominancy, urinary disturbance, and paroxysmal dry cough.
Adolescent
Adult
Aged
Cough
/ complications
Female
GTPase-Activating Proteins
/ genetics
Genes, Dominant
Genetic Linkage
Humans
Immunohistochemistry
Introns
/ genetics
Male
Middle Aged
Muscular Atrophy
/ genetics
Pedigree
Peripheral Nervous System Diseases
/ complications
Polymorphism, Single Nucleotide
Sural Nerve
/ pathology
Urologic Diseases
/ complications
Exome Sequencing
Journal
Journal of human genetics
ISSN: 1435-232X
Titre abrégé: J Hum Genet
Pays: England
ID NLM: 9808008
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
10
02
2020
accepted:
01
04
2020
revised:
01
04
2020
pubmed:
29
4
2020
medline:
9
2
2021
entrez:
29
4
2020
Statut:
ppublish
Résumé
In 2008, we reported a clinically and genetically new type of autosomal dominant disorder of motor and sensory neuropathy with proximal dominancy in the lower extremities, urinary disturbance, and paroxysmal dry cough. To identify the nucleotide variant causative of this disease, we reanalyzed the linkage of the original Japanese pedigree including seven newly ascertained subjects with updated information. We assigned the locus of the disease to 1p13.3-q23 (maximum logarithm-of-odds score = 2.71). Exome sequencing for five patients and one healthy relative from the pedigree revealed 2526 patient-specific single-nucleotide variants (SNVs). By rigorous filtering processes using public databases, our linkage results, and functional prediction, followed by Sanger sequencing of the pedigree and 520 healthy Japanese individuals, we identified an intronic SNV in IQGAP3, a gene known to be associated with neurite outgrowth. Upon pathological examination of the sural nerve, moderate, chronic, mainly axonal neuropathy was observed. By histochemical analyses, we observed a patient-specific increase of IQGAP3 expression in the sural nerve. We concluded that the variant of IQGAP3 is associated with the disease in our pedigree.
Identifiants
pubmed: 32341455
doi: 10.1038/s10038-020-0761-7
pii: 10.1038/s10038-020-0761-7
doi:
Substances chimiques
GTPase-Activating Proteins
0
IQGAP3 protein, human
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
717-725Subventions
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : 26460411
Références
Jerath NU, Shy ME. Hereditary motor and sensory neuropathies: understanding molecular pathogenesis could lead to future treatment strategies. Biochim Biophys Acta. 2015;1852:667–78.
doi: 10.1016/j.bbadis.2014.07.031
Ishiura H, Sako W, Yoshida M, Kawarai T, Tanabe O, Goto J, et al. The TRK-fused gene is mutated in hereditary motor and sensory neuropathy with proximal dominant involvement. Am J Hum Genet. 2012;91:320–9.
doi: 10.1016/j.ajhg.2012.07.014
Tsai PC, Huang YH, Guo YC, Wu HT, Lin KP, Tsai YS, et al. A novel TFG mutation causes Charcot–Marie–Tooth disease type 2 and impairs TFG function. Neurology. 2014;83:903–12.
doi: 10.1212/WNL.0000000000000758
Miura S, Shibata H, Kida H, Noda K, Tomiyasu K, Yamamoto K, et al. Hereditary motor and sensory neuropathy with proximal dominancy in the lower extremities, urinary disturbance, and paroxysmal dry cough. J Neurol Sci. 2008;273:88–92.
doi: 10.1016/j.jns.2008.06.027
Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676–82.
doi: 10.1038/nmeth.2019
Rueden CT, Schindelin J, Hiner MC, DeZonia BE, Walter AE, Arena ET, et al. ImageJ2: ImageJ for the next generation of scientific image data. BMC Bioinform. 2017;18:529.
doi: 10.1186/s12859-017-1934-z
Dyck PJ, Dyck PJB, Engelstad J. Pathological alterations of nerves. In: Dyck PJ, Thomas PK editors. Peripheral neuropathy. Philadelphia: Elsevier Saunders; 2005, p. 733–829.
Wang S, Watanabe T, Noritake J, Fukata M, Yoshimsura T, Itoh N, et al. IQGAP3, a novel effector of Rac1 and Cdc42, regulates neurite outgrowth. J Cell Sci. 2007;120:567–77.
doi: 10.1242/jcs.03356
Nojima H, Adachi M, Matsui T, Okawa K, Tsukita S, Tsukita S. IQGAP3 regulates cell proliferation through the Ras/ERK signaling cascade. Nat Cell Biol. 2008;10:971–8.
doi: 10.1038/ncb1757
Fang X, Zhang B, Thisse B, Bloom GS, Thisse C. IQGAP3 is essential for cell proliferation and motility during zebrafish embryonic development. Cytoskeleton. 2015;72:422–33.
doi: 10.1002/cm.21237
Yang Y, Zhao W, Xu QW, Wang XS, Zhang Y, Zhang J. IQGAP3 promotes EGFR-ERK signaling and the growth and metastasis of lung cancer cells. PLoS One. 2014;9:e97578.
doi: 10.1371/journal.pone.0097578
Qian EN, Han SY, Ding SZ, Lv X. Expression and diagnostic value of CCT3 and IQGAP3 in hepatocellular carcinoma. Cancer Cell Int. 2016;26:55.
doi: 10.1186/s12935-016-0332-3
Xu W, Xu B, Yao Y, Yu X, Cao H, Zhang J, et al. Overexpression and biological function of IQGAP3 in human pancreatic cancer. Am J Transl Res. 2016;8:5421–32.
pubmed: 28078013
pmcid: 5209493
Hu G, Xu Y, Chen W, Wang J, Zhao C, Wang M. RNA interference of IQ motif containing GTPase-activating protein 3 (IQGAP3) inhibits cell proliferation and invasion in breast carcinoma cells. Oncol Res. 2016;24:455–61.
doi: 10.3727/096504016X14685034103635
Shi Y, Qin N, Zhou Q, Chen Y, Huang S, Chen B, et al. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma. J Transl Med. 2017;15:176.
doi: 10.1186/s12967-017-1275-8
Kumar D, Hassan MK, Pattnaik N, Mohapatra N, Dixit M. Reduced expression of IQGAP2 and higher expression of IQGAP3 correlates with poor prognosis in cancers. PLoS One. 2017;12:e0186977.
doi: 10.1371/journal.pone.0186977
Oue N, Yamamoto Y, Oshima T, Asai R, Ishikawa A, Uraoka N, et al. Overexpression of the transmembrane protein IQGAP3 is associated with poor survival of patients with gastric cancer. Pathobiology. 2018;85:192–200.
doi: 10.1159/000481890
Kim WT, Kim YH, Jeong P, Seo SP, Kang HW, Kim YJ, et al. Urinary cell-free nucleic acid IQGAP3: a new non-invasive diagnostic marker for bladder cancer. Oncotarget. 2018;9:14354–65.
doi: 10.18632/oncotarget.24436